MLICM
AVEO

Metropolitan Life Insurance Company (MetLife)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,847
Closed -$127K – 2600
2018
Q3 		$127K Buy
+3,847
New +$98.9K ﹤0.01% 2306

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AVEO Position: Q4 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2018, closing a stake of 3,847 shares — an estimated $127K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVEO in Q3 2018 and held it in 1 quarter. The position peaked at $127K in Q3 2018. 99 funds tracked by Wall St. Rank hold AVEO as of Q4 2018.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,847 AVEO Pharmaceuticals, Inc. shares in Q4 2018, an estimated $127K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s AVEO Pharmaceuticals, Inc. position peaked at $127K in Q3 2018.
  • 99 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.